NeuroVive Pharmaceutical AB Starts Investor Relations Partnership With Laika Consulting

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NeuroVive Pharmaceutical AB (publ) has initiated a collaboration within investor relations communication with Laika Consulting, a company that specializes in helping companies and other entities with their financial communication. The collaboration will start immediately and signals the beginning of an investor relations program to create a better and clearer dialogue with NeuroVive´s shareholders and the equity market at large. The first step will be to conduct a survey with NeuroVive´s over 2 500 shareholders and compile valuable suggestions for the future work at hand.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC